Literature DB >> 2526675

Allergic contact dermatitis caused by transdermal hyoscine.

C R Gordon1, A Shupak, I Doweck, O Spitzer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2526675      PMCID： PMC1836275          DOI： 10.1136/bmj.298.6682.1220

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Delayed hypersensitivity to scopolamine in transdermal therapeutic systems.

Authors:  A H van der Willigen; A P Oranje; E Stolz; T van Joost
Journal:  J Am Acad Dermatol       Date:  1988-01       Impact factor: 11.527

2.  Delayed hypersensitivity to scopolamine delivered by a transdermal device.

Authors:  D J Trozak
Journal:  J Am Acad Dermatol       Date:  1985-08       Impact factor: 11.527

3.  Skin reactions to long-term transdermal clonidine.

Authors:  J B Dick; D B Northridge; A A Lawson
Journal:  Lancet       Date:  1987-02-28       Impact factor: 79.321

4.  [Contact allergy to glycerol trinitrate (nitroderm TTS)].

Authors:  R Weickel; P J Frosch
Journal:  Hautarzt       Date:  1986-09       Impact factor: 0.751
  4 in total
  5 in total

Review 1.  Transdermal scopolamine for prevention of motion sickness : clinical pharmacokinetics and therapeutic applications.

Authors:  Zohar Nachum; Avi Shupak; Carlos R Gordon
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

2.  Scopolamine patch reduces postoperative emesis in paediatric patients following strabismus surgery.

Authors:  Y Horimoto; H Tomie; K Hanzawa; Y Nishida
Journal:  Can J Anaesth       Date:  1991-05       Impact factor: 5.063

Review 3.  Skin sensitivity and transdermal drug delivery. A review of the problem.

Authors:  A J Carmichael
Journal:  Drug Saf       Date:  1994-02       Impact factor: 5.606

Review 4.  Contact dermatitis due to transdermal therapeutic systems: a clinical update.

Authors:  Paolo Romita; Caterina Foti; Gianfranco Calogiuri; Stefania Cantore; Andrea Ballini; Gianna Dipalma; Francesco Inchingolo
Journal:  Acta Biomed       Date:  2018-10-26

5.  Corticosteroid transdermal delivery to target swelling, edema and inflammation following facial rejuvenation procedures.

Authors:  T Iannitti; V Rottigni; B Palmieri
Journal:  Drug Des Devel Ther       Date:  2013-09-26       Impact factor: 4.162
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.